Interstitial lung disease (ILD) secondary to drug-induced lung injury is an increasingly
common cause of morbidity and mortality. The number of drugs associated with the …

The advance of perinatal medicine has improved the survival of extremely premature
babies, thereby creating a new and heterogeneous patient group with limited information on …

Background: Drug-induced interstitial lung disease (DILD) is an increasingly common cause
of morbidity and mortality. However, due to the lack of specificity, DILD detection remains an …

As a dangerous end point, respiratory toxicity can cause serious adverse health effects and
even death. Meanwhile, it is a common and traditional issue in occupational and …

Abstract Hesperidin (HD), a bioflavonoid, has been shown to exert hepatoprotective effects.
Our aim is to investigate the possible protective effects of HD against methotrexate (MTX) …

Purpose Some patients presenting with acute respiratory failure and meeting the Berlin
criteria for acute respiratory distress syndrome (ARDS) lack exposure to common risk factors …

Background Data on characteristics, outcomes, and prognosis of advanced non-small-cell
lung cancer (NSCLC) patients who develop pneumonitis during systemic anti-cancer …

Respiratory toxicity is considered as main cause of drug withdrawal, which could seriously
injure human health or even lead to death. The objective of this investigation was to develop …

Background Drug-induced interstitial lung disease (DI-ILD) is a heterogeneous subgroup of
interstitial lung disease (ILD). The number of molecules involved is increasing with time. Due …

Purpose: Drug-induced interstitial lung disease (DILD) is a rare, but potentially fatal toxicity.
Clinical and radiological features of DILD in the early experimental setting are poorly …